Elicio Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $34,575,000.
Profit Margin
| 2019 | 0 | -12.26M | |
|---|---|---|---|
| 2020 | 2.88M | -15.71M | -545.56% |
| 2021 | 0 | -26.40M | |
| 2022 | 0 | -28.20M | |
| 2023 | 0 | -35.19M |
ELTX Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 2.88M | 0 |
Cost of revenue | 1.17M | 0 | 0 | 1.81M | 0 |
Gross profit | -1.17M | 0 | 0 | 1.06M | 0 |
Operating exp. | |||||
Research and development | 22.67M | 18.10M | 17.93M | 12.71M | 9.54M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 34.57M | 23.73M | 25.47M | 15.72M | 12.34M |
Operating income | -35.74M | -23.73M | -25.47M | -15.72M | -12.34M |
Other income (expenses), net | 550K | -943.29K | -52.96K | 8.94K | 81.48K |
Income before tax | -35.19M | -28.20M | -26.40M | -15.71M | -12.26M |
Income tax expense | 0 | 3.59M | 876.44K | 8.94K | 81.48K |
Net income | -35.19M | -28.20M | -26.40M | -15.71M | -12.26M |
Earnings per share | |||||
Basic EPS | -6.96 | -9.1 | -8.25 | -1.93 | -1.5 |
Diluted EPS | -6.96 | -9.1 | -8.25 | -1.93 | -1.5 |